← All companies

CUVL

Clinuvel Pharmaceuticals Limited

CUVL Nasdaq American Depositary Receipts EDGAR ↗

$6.84

-0.10 -1.44%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$5.98 – $9.00

Recent SEC filings

28 most recent

Annual, quarterly & current reports

6-K Jul 30, 2026 6-K Jul 28, 2026 6-K Jul 27, 2026 6-K Jul 23, 2026 6-K Jul 22, 2026 6-K Jul 22, 2026

Other filings

SEC STAFF ACTION Jul 17, 2026 424B3 Jul 17, 2026 CERT Jul 17, 2026 20FR12B Jun 15, 2026 DRS/A Apr 17, 2026 DRS/A Mar 30, 2026 DRS/A Mar 4, 2026 DRS Dec 18, 2025 EFFECT Item F-6; Item 2021-08-16; Item 09:00:00 Aug 16, 2021 F-6 Aug 6, 2021 424B3 Nov 26, 2010 424B3 Mar 20, 2006 SUPPL AUTO-GENERATED PAPER DOCUMENT May 6, 2005 SUPPL AUTO-GENERATED PAPER DOCUMENT Apr 15, 2005 SUPPL AUTO-GENERATED PAPER DOCUMENT Jan 5, 2005 ARS AUTO-GENERATED PAPER DOCUMENT Oct 5, 2004 SUPPL AUTO-GENERATED PAPER DOCUMENT Oct 5, 2004 SUPPL AUTO-GENERATED PAPER DOCUMENT Aug 23, 2004 F-6 FORM F-6 Jun 22, 2004 SUPPL AUTO-GENERATED PAPER DOCUMENT May 7, 2004 ARS AUTO-GENERATED PAPER DOCUMENT May 7, 2004 12G3-2B AUTO-GENERATED PAPER DOCUMENT May 7, 2004